Angelica Maria Lucchese, Antonio Nocchi Kalil, Alessandro L Diniz, Karl J Oldhafer, Timothy M Pawlik, René Adam, Olivier Soubrane, Maria Ignez Braghiroli, Ricardo Lemos Cotta-Pereira
{"title":"MELANOMAS, SARCOMAS, AND RENAL METASTASES IN THE LIVER: HOW TO TREAT?","authors":"Angelica Maria Lucchese, Antonio Nocchi Kalil, Alessandro L Diniz, Karl J Oldhafer, Timothy M Pawlik, René Adam, Olivier Soubrane, Maria Ignez Braghiroli, Ricardo Lemos Cotta-Pereira","doi":"10.1590/0102-6720202400072e1866","DOIUrl":null,"url":null,"abstract":"<p><p>Liver metastases from melanomas, sarcomas, and renal tumors are less frequent. Treatment and prognosis will depend on whether they are isolated or multiple, size and location, the presence or absence of extrahepatic neoplastic disease, age, stage of the initial disease, initial treatments instituted, time of evolution, and clinical condition of the patient. Recently, a high number of oncological therapies including monotherapy or in combination, neoadjuvants or adjuvants, and immuno-oncological treatments have been developed and tested, increasing disease-free time and survival.</p>","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"37 ","pages":"e1866"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11774096/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1590/0102-6720202400072e1866","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Liver metastases from melanomas, sarcomas, and renal tumors are less frequent. Treatment and prognosis will depend on whether they are isolated or multiple, size and location, the presence or absence of extrahepatic neoplastic disease, age, stage of the initial disease, initial treatments instituted, time of evolution, and clinical condition of the patient. Recently, a high number of oncological therapies including monotherapy or in combination, neoadjuvants or adjuvants, and immuno-oncological treatments have been developed and tested, increasing disease-free time and survival.